Related Experiment Video

Updated: Jun 1, 2026

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System
07:09

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System

Published on: May 10, 2020

Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha

Anna Mizutani1, Daizo Koinuma, Shuichi Tsutsumi

  • 1Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

The Journal of Biological Chemistry
|June 8, 2011
PubMed

Insights

Transforming growth factor-β (TGF-β) signaling specificity relies on cell-specific transcription factors like HNF4α. These factors bind Smad complexes to regulate target genes, impacting cell type-dependent gene transcription.

Area of Science:

  • Cellular and Molecular Biology
  • Gene Regulation
  • Signal Transduction

Background:

  • Transforming growth factor-β (TGF-β) signaling is crucial for cellular processes.
  • Smad proteins are key mediators of TGF-β transcriptional responses.
  • Cell type-specific transcription factors influence TGF-β pathway outcomes.

Purpose of the Study:

  • To investigate cell type-specific Smad2/3 binding regions in HepG2 and HaCaT cells.
  • To elucidate the role of transcription factors in TGF-β-induced gene regulation.
  • To identify mechanisms of context-dependent TGF-β transcriptional control.

Main Methods:

  • Chromatin immunoprecipitation sequencing (ChIP-seq) to map Smad2/3 and HNF4α binding sites.
  • Comparative analysis of Smad2/3 binding regions in HepG2 and HaCaT cells.
  • Bioinformatic analysis to identify enriched motifs in cell type-specific binding regions.

Main Results:

  • 81% of Smad2/3 binding regions were cell type-specific between HepG2 and HaCaT cells.
  • Hepatocyte nuclear factor 4α (HNF4α) motif enrichment in HepG2-specific Smad2/3 binding regions.
  • Significant overlap between Smad2/3 and HNF4α binding sites, with MIXL1 identified as a combinatorial target.

Conclusions:

  • HNF4α binding on Smad2/3 sites is critical for HepG2-specific TGF-β transcriptional regulation.
  • Cell type-specific transcription factors modulate TGF-β-Smad signaling pathway activity.
  • Understanding these interactions is key to deciphering context-dependent gene expression.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Cell Type-specific Gene Expression Profiling in the Mouse Liver10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...